Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Triple-negative breast cancer.

The New England journal of medicine - 11 Nov 2010

Foulkes William D, Smith Ian E, Reis-Filho Jorge S

Abstract excerpt

Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment.

Topics

Join the communities discussing this publication.

Antineoplastic Agents
Breast Neoplasms
Genes, BRCA1
Prognosis
Receptor, ErbB-2
Receptors, Estrogen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Receptors, Progesterone

Source

Identifiers

PMID: 21067385
DOI: 10.1056/NEJMra1001389

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Triple-negative breast cancer.PMID 21067385Read ↗

Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of researchSemantic proximity Read ↗

Triple-negative breast cancer.Semantic proximity Read ↗

[Triple-negative breast cancer: molecular characteristics and potential therapeutic approaches].Semantic proximity Read ↗

Triple-negative breast cancer: unique biology and its management.Semantic proximity Read ↗

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.Semantic proximity Read ↗

Triple-negative breast cancer and the need for new therapeutic targets.Semantic proximity Read ↗

New Biomarkers and Treatment Advances in Triple-Negative Breast CancerSemantic proximity Read ↗

Treatment options for patients with triple-negative breast cancer.Semantic proximity Read ↗

Triple negative breast cancer: looking for the missing link between biology and treatments.Semantic proximity Read ↗

Triple-negative breast cancers — a panoply of cancer typesSemantic proximity Read ↗

What Is the Difference Between Triple-Negative and Basal Breast Cancers?Semantic proximity Read ↗

[Triple-negative breast cancer : Classification, current concepts, and therapy-related factors].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.